BOSTON--(BUSINESS WIRE)--Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in the life science and technology segments, today announced that Veranex, a newly formed concept-to-commercialization service provider dedicated to the medtech industry, has acquired Boston Healthcare Associates (BHA), a global strategy consulting firm. In conjunction with the acquisition of BHA, Veranex, which was formed in partnership with global growth investors Summit Partners, has acquired two other complementary businesses. Outcome Capital served as the exclusive strategic and financial advisor to Boston Healthcare Associate for the transaction.
Boston Healthcare Associates is a highly specialized, global healthcare consulting firm that helps leading medical device, diagnostic and biopharma clients to unlock the value of innovation. The company’s offering includes insights and analysis in reimbursement, pricing, health economics, market assessment and business strategy. Veranex combines the industry’s key pillars of design and engineering, regulatory, clinical, and market access into a single-source solution.
“We are excited that BHA’s global market access and strategy expertise is now a foundational part of Veranex,” said Joseph Ferrara, CEO of BHA. “We are confident that with Veranex we will be able to offer a more comprehensive range of services and solutions to our life sciences and medtech clients. With the strategic perspective of Outcome’s recognized expertise in the biomedical field, BHA was able to devise and communicate a market-aligned strategy leading to the completion of the transaction efficiently and effectively. We are very pleased with the way Outcome supported us throughout this process,” Ferrara added
About Outcome Capital
Outcome Capital is a unique and highly specialized life science advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to merger & acquisition, partnering, financing and strategic advisory. The firm uses its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and strategic markets and implementing the best path for success. Outcome Capital’s strength stems from its multi-disciplinary team consisting of industry veterans who draw from their wide range of scientific, operational, strategic and transactional expertise across the value chain, and broad industry network and relationships. Comprised of former CEOs, PhD/MD level scientists and clinicians, business development executives and experienced commercialization experts, our team is driven to propel innovation from bench to bedside.
About Boston Healthcare Associates
Boston Healthcare is a global strategy consulting firm that advises clients on how to optimize innovation value in a complex clinical and economic environment. We help clients unlock the value of medical devices, diagnostics, and biopharmaceuticals that have the potential to transform patient care and significantly improve health outcomes.
BHA’s multi-disciplinary, global teams bring deep industry and functional expertise and a range of perspectives to initiate change through leading-edge insights and advisory. We work in a uniquely collaborative model across the firm and throughout all levels of an organization to deliver results that help our clients grow and achieve.
About Veranex
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance for each of its four concept-through-commercialization pillars — engineering and design, clinical, market access, and regulatory — Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its comprehensive solutions unify the entire development process. For more information, visit VeranexSolutions.com.
About Summit Partners
Founded in 1984, Summit Partners is a global alternative investment firm that is currently managing more than $28 billion in capital dedicated to growth equity, fixed income and public equity opportunities. Summit Partners invests across growth sectors of the economy and has invested in more than 500 companies in healthcare and life sciences, technology and other growth industries. Notable healthcare and life sciences companies backed by Summit Partners include Abode Healthcare, Integrated DNA Technologies, InnovaCare Health, LifeStance Health, PharmScript, Sound Physicians, U.S. Renal Care and Viroclinics-DDL. Summit Partners maintains offices in North America and Europe and invests in companies around the world. For more information, please see www.summitpartners.com.
